Table 2.
Correlation of MMP-7 expression with clinicopathologic characteristics of LAC patients.
Variables | Cases (n) | MMP-7 | χ2 | P | |
---|---|---|---|---|---|
- | + | ||||
Total | 50 | 12 | 38 | ||
Age (years) | |||||
<60 | 28 | 7 | 21 | 0.034 | 0.853 |
≥60 | 22 | 5 | 17 | ||
Gender | |||||
Male | 31 | 8 | 23 | 0.143 | 0.705 |
Female | 19 | 4 | 15 | ||
TNM staging | |||||
I+II | 29 | 9 | 20 | 1.836 | 0.175 |
III+IV | 21 | 3 | 18 | ||
Tumor size | |||||
T1+T2 | 42 | 10 | 32 | 0.005 | 0.943 |
T3+T4 | 8 | 2 | 6 | ||
Lymph node metastases | |||||
No | 22 | 9 | 13 | 6.035 | 0.014 |
Yes | 28 | 3 | 25 |
LAC, lung adenocarcinoma.